The Department of Internal Medicine is pleased to announce a transition in Rheumatology leadership. They express their gratitude to Dr. Daniel Clegg for his excellent service in the department and welcome Dr. Christopher Jackson as the Interim Chair. ... Read MoreInternal Medicine
Welcome to the Division of Rheumatology
The University of Utah Division of Rheumatology is active in the clinical investigation of new therapies for rheumatic disorders. We are recognized both nationally and internationally for our contributions and expertise in inception, design, conduct and reporting of clinical trials.
The Division of Rheumatology faculty members provide quality care at the University of Utah Health Sciences Center and the Veterans Affairs Medical Center. In addition to our patient care and research, we also provide training through our Fellowship Program and the Annual Utah Rheumatology Association Meeting.
The division seeks to provide exemplary patient care; empowering patient and medical education and collaborative clinical and translational research that will help better understand rheumatic diseases.
Internal Medicine Faculty Accepted into Vice President's Clinical & Translational (VPCAT) Research Scholars Program
Congratulations to four faculty members from the Department of Internal Medicine to be selected for the 2021-2022 Vice President's Clinical & Translational (VPCAT) Research Scholars: Dr. Rebecca Overbury, Division of Rheumatology; Dr. Candace Reno, Division of Endocrinology, Metabolism & Diabetes; Dr. Kevin Shah, Division of Cardiovascular Medicine; & Sumati Gupta, Division of Oncology. ... Read MoreInternal Medicine
Dr. Daniel Clegg, MD, Chief of the Division of Rheumatology is retiring at the beginning of 2021. The Department of Internal Medicine thanks Dr. Clegg for his 21 years of outstanding service at the University of Utah and wishes him the best in his future endeavors. ... Read MoreInternal Medicine
Immune checkpoint inhibitor use in the treatment of a variety of cancers continues to increase with reports of improved survival with these drugs. These medications have side effects known as immune related adverse events (irAEs). The University of Utah’s Rheumatology clinic is prepared to help manage this novel field of rheumatic irAEs. ... Read MoreInternal Medicine
In the past three years, the Division of Rheumatology has developed and piloted a team-based clinical care model as a response to an unprecedented volume of new patient evaluations and other unique challenges. ... Read MoreInternal Medicine
Since the fall of 2018, the adult center for childhood onset rheumatic disease has attempted to resolve a unique challenge: with 20% of autoimmune diseases diagnosed in adolescence, how do we care for patients as they transition from children into adults? ... Read MoreInternal Medicine